Furthermore, Jak2 interacts with Lyn and maintain Lyn kinase activity in CML cells through SET-PP2A-Shp1 pathway [6]. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.